Promotion of osteogenesis in tissue‐engineered bone by pre‐seeding endothelial progenitor cells‐derived endothelial cells
Open Access
- 7 March 2008
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 26 (8), 1147-1152
- https://doi.org/10.1002/jor.20609
Abstract
In addition to a biocompatible scaffold and an osteogenic cell population, tissue-engineered bone requires an appropriate vascular bed to overcome the obstacle of nutrient and oxygen transport in the 3D structure. We hypothesized that the addition of endothelial cells (ECs) may improve osteogenesis and prevent necrosis of engineered bone via effective neovascularization. Osteoblasts and ECs were differentiated from bone marrow of BALB/c mice, and their phenotypes were confirmed prior to implantation. Cylindrical porous polycaprolactone (PCL)-hydroxyapatite (HA) scaffolds were synthesized. ECs were seeded on scaffolds followed by seeding of osteoblasts in the EC-OB group. In the OB group, scaffolds were only seeded with osteoblasts. The cell-free scaffolds were denoted as control group. A 0.4-cm-long segmental femur defect was established and replaced with the grafts. The grafts were evaluated histologically at 6 weeks postimplantation. In comparison with the OB group, the EC-OB group resulted in a widely distributed capillary network, osteoid generated by osteoblasts and absent ischemic necroses. Pre-seeding scaffold with ECs effectively promoted neovascularization in grafts, prevented the ischemic necrosis, and improved osteogenesis. The integration of bone marrow-derived ECs and osteoblasts in porous scaffold is a useful strategy to achieve engineered bone. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:1147–1152, 2008Keywords
This publication has 20 references indexed in Scilit:
- The Roles of Hypoxia in theIn VitroEngineering of TissuesTissue Engineering, 2007
- Engineered Adipose Tissue Supplied by Functional MicrovesselsTissue Engineering, 2003
- Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communicationAmerican Journal of Physiology-Cell Physiology, 2002
- Angiogenesis TherapyCirculation, 2001
- Controlled growth factor release from synthetic extracellular matricesNature, 2000
- Angiogenesis and Bone GrowthTrends in Cardiovascular Medicine, 2000
- Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularizationJCI Insight, 2000
- Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJCI Insight, 2000
- Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matricesJournal of Biomedical Materials Research, 1999